Assignee
LTS LOHMANN THERAPIE SYSTEME AG
DE·100 granted patents·103 pending applications·83 citations·filing 2012–2025
Top patents by PatentIndex Score
203 records- 0196US10034841B2Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Jul 31, 2018·15 cites·11 claims
- 0295US10898449B2Transdermal therapeutic system containing asenapineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Granted Jan 26, 2021·6 cites·29 claims
- 0394US10881607B2Composition for transdermal delivery of cationic active agentsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Jan 5, 2021·7 cites·21 claims
- 0494US9717698B2Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracyLTS LOHMANN THERAPIE SYSTEME AG·Filed 2016·Granted Aug 1, 2017·13 cites·22 claims
- 0592US10980753B2Transdermal therapeutic system containing asenapineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Apr 20, 2021·5 cites·28 claims
- 0690US11337932B2Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutyleneLTS LOHMANN THERAPIE SYSTEME AG·Filed 2017·Granted May 24, 2022·4 cites·19 claims
- 0790US11033512B2Transdermal therapeutic system containing asenapine and silicone acrylic hybrid polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Jun 15, 2021·5 cites·19 claims
- 0887US11648213B2Transdermal therapeutic system containing asenapineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted May 16, 2023·3 cites·20 claims
- 0987US11576874B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Feb 14, 2023·4 cites·17 claims
- 1086US11992561B2Oral thin film of polyvinyl alcohol and polyvinyl alcohol-polyethylene glycol graft copolymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted May 28, 2024·1 cites·15 claims
- 1182US10583093B2Transdermal therapeutic system with fentanyl or related substancesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Mar 10, 2020·2 cites·19 claims
- 1282US9637293B2Childproof highly-inert packaging for individually dosed films containing an active ingredientLTS LOHMANN THERAPIE SYSTEME AG·Filed 2016·Granted May 2, 2017·4 cites·2 claims
- 1381US10485967B2System for the transdermal delivery of active ingredientLTS LOHMANN THERAPIE SYSTEME AG·Filed 2014·Granted Nov 26, 2019·4 cites·1 claims
- 1480US10398746B2Edible oral strip or wafer dosage form containing ion exchange resin for taste maskingLTS LOHMANN THERAPIE SYSTEME AG·Filed 2017·Granted Sep 3, 2019·2 cites·22 claims
- 1577US11304912B2Transdermal therapeutic system on the basis of adhesive plasticizer-polymer matricesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Apr 19, 2022·1 cites·16 claims
- 1677US10940122B2Transdermal therapeutic system with fentanyl or related substancesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Mar 9, 2021·0 cites·17 claims
- 1774US10744176B2Edible oral strip or wafer dosage form containing ion exchange resin for taste maskingLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Aug 18, 2020·0 cites·21 claims
- 1874US9616045B2Transdermal therapeutic system having improved long-term wearing comfortLTS LOHMANN THERAPIE SYSTEME AG·Filed 2014·Granted Apr 11, 2017·0 cites·32 claims
- 1973US12168074B2Transdermal therapeutic system for the transdermal administration of guanfacine comprising a silicone polymerLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Dec 17, 2024·0 cites·18 claims
- 2072US12485099B2Transdermal therapeutic system containing asenapine and polysiloxane or polyisobutyleneLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted Dec 2, 2025·0 cites·27 claims
- 2172US12138353B2Transdermal therapeutic system containing asenapineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2021·Granted Nov 12, 2024·0 cites·20 claims
- 2272US9421174B2Transdermal therapeutic system with high rate of utilization of active substance and dosing accuracyLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Aug 23, 2016·1 cites·22 claims
- 2372US2021287764A1System for determining a suitability of an active ingredient to be applied transdermally or transmucosally and corresponding methodLTS LOHMANN THERAPIE SYSTEME AG·Filed 2021·Application pending·0 cites
- 2471US12433851B2Controlling water release from a dimensionally stable aqueous compositionLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Oct 7, 2025·0 cites·19 claims
- 2571US12054335B2Device and method for dispensing active ingredient-containing or active ingredient-carrying stripsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Aug 6, 2024·0 cites·12 claims
- 2671US11534589B2Iontophoretic microneedle deviceLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Dec 27, 2022·2 cites·15 claims
- 2770US2024139098A1Microneedle system for applying glucagon-like peptide analoguesLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Application pending·0 cites
- 2869US12070521B2Method for adjusting the release of active agent in a transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted Aug 27, 2024·0 cites·10 claims
- 2969US11478434B2Fibre-free transdermal therapeutic system and method for its productionLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Oct 25, 2022·0 cites·19 claims
- 3069US10926941B2Device and method for dispensing active ingredient-containing or active ingredient-carrying stripsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2018·Granted Feb 23, 2021·1 cites·10 claims
- 3169US10709669B2Microreservoir system based on polysiloxanes and ambiphilic solventsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Jul 14, 2020·0 cites·15 claims
- 3268US12427119B2Transdermal delivery system including an interface mediatorLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Granted Sep 30, 2025·0 cites·19 claims
- 3368US10596126B2Transdermal therapeutic system comprising active ingredient particles and having increased active ingredient fluxLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Mar 24, 2020·0 cites·18 claims
- 3467US11529345B2Buprenorphine transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Granted Dec 20, 2022·0 cites·48 claims
- 3567US10335377B2Over-patch having improved compatibility and a long adhesion duration and method for producing said over-patchLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Jul 2, 2019·1 cites·15 claims
- 3667US2020316055A1Transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
- 3767US2023248661A1Transdermal Delivery System Containing RotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Application pending·0 cites
- 3865US9895521B2Transdermal therapeutic system with pressure generating deviceLTS LOHMANN THERAPIE SYSTEME AG·Filed 2016·Granted Feb 20, 2018·1 cites·9 claims
- 3965US2019192506A1Transdermal therapeutic system for administering the active substance buprenorphineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Application pending·0 cites
- 4064US11690799B2Microneedle system for applying interferonLTS LOHMANN THERAPIE SYSTEME AG·Filed 2019·Granted Jul 4, 2023·1 cites·21 claims
- 4164US9488409B2Method for neutralizing or recycling carrier materials for film-like coatingsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2013·Granted Nov 8, 2016·0 cites·8 claims
- 4264US2022273928A1Microneedle system for administering liquid formulationsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 4364US2023172845A1Method for producing an, in particular oral, active substance laminate, and active substance laminate, in particular oral active substance laminateLTS LOHMANN THERAPIE SYSTEME AG·Filed 2023·Application pending·0 cites
- 4463US11634268B2Device and method for dispensing active ingredient-containing or active ingredient-carrying stripsLTS LOHMANN THERAPIE SYSTEME AG·Filed 2021·Granted Apr 25, 2023·0 cites·9 claims
- 4563US2022160646A1Oral thin filmLTS LOHMANN THERAPIE SYSTEME AG·Filed 2021·Application pending·0 cites
- 4663US2023106505A1Iontophoretic microneedle deviceLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 4762US12329613B2Electrically-heatable plasterLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted Jun 17, 2025·0 cites·8 claims
- 4862US11426358B2Medical active substance patch with reduced optical conspicuousness on the skinLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Granted Aug 30, 2022·0 cites·12 claims
- 4962US2022151949A1Multi-Day Patch for the Transdermal Administration of RotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 5061US2020306204A1Transdermal delivery system comprising buprenorphineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2020·Application pending·0 cites
Showing the top 50 of 203 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when LTS LOHMANN THERAPIE SYSTEME AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →